Skip to main content

Histopathology and Imaging

Histological Features of Giant Cell Arteritis

  • Chapter
  • First Online:
Large and Medium Size Vessel and Single Organ Vasculitis

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 818 Accesses

Abstract

The gold standard to diagnose giant cell arteritis is temporal artery biopsy. The classical histologic picture of GCA is a transmural inflammatory infiltrate comprising lymphocytes, macrophages and, in about 50% of cases, giant cells. However, in some patients the inflammation may be restricted to the adventitial layer, to the vasa vasorum, or to the small vessels that surround the temporal artery.

Imaging techniques play a pivotal role both in the diagnosis and in the follow-up of patients with giant cell arteritis. According to the recommendations by the European League Against Rheumatism, imaging procedures should be the first diagnostic test, while temporal artery biopsy should be performed when imaging findings are not contributory. Color Doppler sonography is the modality of choice to image the temporal arteries: inflamed arteries typically show a positive “halo sign,” i.e., a hypoechoic (dark) halo around the temporal artery lumen. Color Doppler sonography can also be used to examine the superficial large vessels and to define whether there are lumen changes such as stenoses or aneurysms. Deep, large vessels such as the aorta are best imaged by computerized tomography or magnetic resonance imaging: signs of vasculitis are increased thickness of the vessel wall with enhancement. 18F-Fluorodeoxyglucose positron emission tomography can also be used to demonstrate arterial inflammation. 18F-Fluorodeoxyglucose positron emission tomography can visualize all large vessels and is very sensitive: a vascular smooth, linear pattern with Fluorodeoxyglucose uptake that affects long segments of the arteries is consistent with vasculitis. Imaging changes tend to improve or resolve the following treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.

    Article  PubMed  Google Scholar 

  2. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–71.

    Article  PubMed  Google Scholar 

  3. Breuer GS, Nesher R, Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol. 2009;27:S10–3.

    CAS  PubMed  Google Scholar 

  4. Narvaez J, Bernad B, Roig-Vilaseca D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum. 2007;37:13–9.

    Article  CAS  PubMed  Google Scholar 

  5. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc. 1976;51:504–10.

    CAS  PubMed  Google Scholar 

  6. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.

    Article  CAS  PubMed  Google Scholar 

  7. Giuseppe G, Francesco M, Luca C, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatol. (Oxford). 2015;54(3):400–4.

    Google Scholar 

  8. Cavazza A, Muratore F, Boiardi L, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol. 2014;38:1360–70.

    Article  PubMed  Google Scholar 

  9. Muratore F, Cavazza A, Boiardi L, et al. Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthritis Care Res (Hoboken). 2016;68:865–70.

    Article  CAS  Google Scholar 

  10. Lally L, Pernis A, Narula N, Huang WT, Spiera R. Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis. Rheumatology (Oxford). 2015;54:554–8.

    Article  CAS  Google Scholar 

  11. Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–43.

    Article  PubMed  Google Scholar 

  12. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47:403–8.

    Article  CAS  Google Scholar 

  13. Germano G, Monti S, Ponte C, et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol. 2017;35(Suppl 103):194–8.

    PubMed  Google Scholar 

  14. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336–42.

    Article  CAS  PubMed  Google Scholar 

  15. Rinagel M, Chatelus E, Jousse-Joulin S, et al. Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature. Autoimmun Rev. 2019;18:56–61.

    Article  PubMed  Google Scholar 

  16. Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord. 2010;11:44.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Aschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign—a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med. 2013;34:47–50.

    CAS  PubMed  Google Scholar 

  18. Aschwanden M, Imfeld S, Staub D, et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol. 2015;33:S113–5.

    Google Scholar 

  19. Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology (Oxford). 2012;51:1999–2003.

    Article  CAS  Google Scholar 

  20. Bley TA, Uhl M, Carew J, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28:1722–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Ghinoi A, Zuccoli G, Nicolini A, et al. 1T magnetic resonance imaging in the diagnosis of giant cell arteritis: comparison with ultrasonography and physical examination of temporal arteries. Clin Exp Rheumatol. 2008;26:S76–80.

    CAS  PubMed  Google Scholar 

  22. Bley TA, Ness T, Warnatz K, et al. Influence of corticosteroid treatment on MRI findings in giant cell arteritis. Clin Rheumatol. 2007;26:1541–3.

    Article  CAS  PubMed  Google Scholar 

  23. Czihal M, Zanker S, Rademacher A, et al. Sonographic and clinical pattern of extracranial and cranial giant cell arteritis. Scand J Rheumatol. 2012;41:231–6.

    Article  CAS  PubMed  Google Scholar 

  24. Loffler C, Hoffend J, Benck U, Kramer BK, Bergner R. The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: a retrospective study. Clin Rheumatol. 2017;36:2079–86.

    Article  PubMed  Google Scholar 

  25. Geiger J, Bley T, Uhl M, Frydrychowicz A, Langer M, Markl M. Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging. 2010;31:470–4.

    Article  PubMed  Google Scholar 

  26. Gotway MB, Araoz PA, Macedo TA, et al. Imaging findings in Takayasu’s arteritis. AJR Am J Roentgenol. 2005;184:1945–50.

    Article  PubMed  Google Scholar 

  27. Prieto-Gonzalez S, Arguis P, Garcia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis. 2012;71:1170–6.

    Article  PubMed  Google Scholar 

  28. Pipitone NAM, Versari A, Salvarani C. Usefulness of PET in recognizing and managing vasculitides. Curr Opin Rheumatol. 2018;30:24–9.

    Article  PubMed  Google Scholar 

  29. Einspieler I, Thurmel K, Pyka T, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42:1012–24.

    Article  CAS  PubMed  Google Scholar 

  30. Balink H, Houtman PM, Collins J. 18F-FDG PET versus PET/CT as a diagnostic procedure for clinical suspicion of large vessel vasculitis. Clin Rheumatol. 2011;30:1139–41.

    Article  PubMed  Google Scholar 

  31. Muratore F, Crescentini F, Spaggiari L, et al. Aortic dilatation in patients with large vessel vasculitis: a longitudinal case control study using PET/CT. Semin Arthritis Rheum. 2019;48:1074–82.

    Article  PubMed  Google Scholar 

  32. Meller J, Strutz F, Siefker U, et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30:730–6.

    Article  CAS  PubMed  Google Scholar 

  33. Hautzel H, Sander O, Heinzel A, Schneider M, Muller HW. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med. 2008;49:1107–13.

    Article  PubMed  Google Scholar 

  34. Slart RHJA. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45:1250–69.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Castellani M, Vadrucci M, Florimonte L, Caronni M, Benti R, Bonara P. 18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis. Ann Nucl Med. 2016;30:409–20.

    Article  CAS  PubMed  Google Scholar 

  36. Belhocine T, Blockmans D, Hustinx R, Vandevivere J, Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging. 2003;30:1305–13.

    Article  PubMed  Google Scholar 

  37. Besson FL, Parienti JJ, Bienvenu B, et al. Diagnostic performance of (1)(8)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2011;38:1764–72.

    Article  PubMed  Google Scholar 

  38. Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine (Baltimore). 2015;94:e622.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Lee YH, Choi SJ, Ji JD, Song GG. Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis: a meta-analysis. Z Rheumatol. 2016;75:924–31.

    Article  CAS  PubMed  Google Scholar 

  40. Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2012;39:344–53.

    Article  PubMed  Google Scholar 

  41. Lariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: a real-life prospective study. Medicine (Baltimore). 2016;95:e4146.

    Article  Google Scholar 

  42. Quinn KA, Ahlman MA, Malayeri AA, et al. Comparison of magnetic resonance angiography and (18)F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis. Ann Rheum Dis. 2018;77:1165–71.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46:1634–42.

    Article  PubMed  Google Scholar 

  44. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55:131–7.

    Article  PubMed  Google Scholar 

  45. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford). 2008;47:1179–84.

    Article  CAS  Google Scholar 

  46. de Boysson H, Liozon E, Lambert M, et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: a multicenter cohort of 130 patients. Medicine (Baltimore). 2016;95:e3851.

    Article  Google Scholar 

  47. Kermani TA, Diab S, Sreih AG, et al. Arterial lesions in giant cell arteritis: a longitudinal study. Semin Arthritis Rheum. 2019;48:707–13.

    Article  PubMed  Google Scholar 

  48. Aschwanden M, Schegk E, Imfeld S, et al. Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study. Rheumatology (Oxford). 2019;58(5):792–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicolò Pipitone .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pipitone, N. (2021). Histopathology and Imaging. In: Salvarani, C., Boiardi, L., Muratore, F. (eds) Large and Medium Size Vessel and Single Organ Vasculitis. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-030-67175-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-67175-4_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-67174-7

  • Online ISBN: 978-3-030-67175-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics